Cited by 2Inflammatory Bowel DiseaseHealthcare Policy and ManagementDiverticular Disease and Complications

The DOI matches its Crossref record; 27 of the 30 references it cites were found in a registry or an index.

Inflammatory Bowel Disease in Appalachian Kentucky: An Investigation of Outcomes and Health Care Utilization

Open access

Abstract

Background: Rural residence has been associated with a lower incidence of inflammatory bowel disease (IBD) but higher health care utilization and worse outcomes. Socioeconomic status is intrinsically tied to both IBD incidence and outcomes. Inflammatory bowel disease outcomes have not been investigated in Appalachia: a rural, economically distressed region rife with risk factors for both increased incidence and unfavorable outcomes. Methods: Hospital inpatient discharge and outpatient services databases were utilized to assess outcomes in patients diagnosed with either Crohn’s disease (CD) or ulcerative colitis (UC) in Kentucky. Encounters were classified by patient residence in Appalachian or non-Appalachian counties. Data were reported as crude and age-adjusted rates of visits per 100,000 population per year collected in 2016 to 2019. National inpatient discharge data from 2019, stratified by rural and urban classification codes, were utilized to compare Kentucky to national trends. Results: Crude and age-adjusted rates of inpatient, emergency department and outpatient encounters were higher in the Appalachian cohort for all 4 years observed. Appalachian inpatient encounters are more frequently associated with a surgical procedure (Appalachian, 676, 24.7% vs non-Appalachian, 1408, 22.2%; P = .0091). In 2019, the Kentucky Appalachian cohort had significantly higher crude and age-adjusted rates of inpatient discharges for all IBD diagnoses compared with national rural and nonrural populations (crude 55.2; 95% CI, 50.9-59.5; age-adjusted 56.7; 95% CI, 52.1-61.3). Conclusions: There is disproportionately higher IBD health care utilization in Appalachian Kentucky compared with all cohorts, including the national rural population. There is a need for aggressive investigation into root causes of these disparate outcomes and identification of barriers to appropriate IBD care.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ibd/izad096

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Kentucky displayed the highest AAMR, which can be explained by the low-resourced Appalachian counties that are dense in vulnerable populations at the risk of intestinal pathologies.

    “States such as Kentucky displayed the highest AAMR, which can be explained by the low‐resourced Appalachian counties that are dense in vulnerable populations at the risk of intestinal pathologies [22].”

    From Trends and Demographics of Vascular Intestinal Diseases‐Related Mortality Among Adults Living in United States From 1999 to 2020; A CDC Wonder Analysis (2025) · cites this paper as [22]

    The Introduction (page unavailable) describes most Appalachian Kentucky counties as economically distressed and their residents as facing risks for inflammatory bowel disease and poorer outcomes. The Health Care Utilization Rate Analysis (page unavailable) reports higher age-adjusted rates of IBD-related visits and admissions, not mortality. It does not establish that Kentucky had the highest age-adjusted mortality rate (AAMR) or that conditions in Appalachian counties explain such a rate. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

3 of the 30 references couldn’t be matched to a known paper.

Research works printed but not linked: 10

  1. Pollard, 2021, The Appalachian Region: A Data Overview from the 2015-2019 American Community Survey Chartbook
  2. Benchimol, 2018, Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study, Clin Epidemiol, 10, 1613, 10.2147/CLEP.S178056 · DOI
  3. Kentucky Cabinet for Health and Family Services-Office of Health Policy, 2020, Kentucky Inpatient Hospitalization Claims Files, 2016-2019
  4. Kentucky Cabinet for Health and Family Services-Office of Health Policy, 2020, Kentucky Outpatient Services Claims Files, 2016-2019
  5. Agency for Healthcare Research and Quality, 2022, Healthcare Cost and Utilization Project (HCUP)
  6. Appalachian Regional Commission (ARC), 2021, Subregions in Appalachia
  7. Coffey, 2008, Methods Applying AHRQ Quality Indicators to Healthcare Cost and Utilization Project (HCUP) Data for the Sixth (2008) National Healthcare Quality Report
  8. Census Bureau, 2021, County Population Totals: 2010-2020
  9. Houchens, 2015, Final Report on Calculating National Inpatient Sample (NIS) Variances for Data Years 2012 and Later
  10. Houchens, 2010, Inferences with HCUP State Databases Final Report

Cited by

Sorted by citations

Metadata

Authors
Rhudy, C. N., Perry, C. L., Hawk, G. S., Flomenhoft, D. R., Talbert, J. C., & Barrett, T. A.
Affiliations
  • University of Kentucky HealthCare (US)
  • University of Kentucky (US)
Venue
Inflammatory Bowel Diseases
Published
2023-06-06
Volume
30
Issue
3
Pages
410-422
ISSN
  • 1078-0998 (ISSN-L)
  • 1536-4844
OpenAlex
W4379600734
Cited by
2
References
30
Citations by year
2025: 2
FWCI
0.33
Type
journal article
Language
en
Open access
Locations
  • Inflammatory Bowel Diseases (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Center for Advancing Translational Sciences (UL1TR001998)
  • National Institutes of Health (TL1TR001997)
  • National Institute of Diabetes and Digestive and Kidney Diseases (2RO1 DK095662-10A1, R21DK118954)
Topics
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
  • Health Sciences › Medicine › Surgery › Diverticular Disease and Complications
Keywords
inflammatory bowel disease, Crohn's disease
MeSH terms
Child, Preschool, Colitis, Ulcerative, Crohn Disease, Humans, Kentucky, Patient Acceptance of Health Care, Inflammatory Bowel Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review